Metastatic renal cell carcinoma: results of a population-based study with 25 years follow-up
A Schlesinger-Raab, U Treiber, D Zaak… - European Journal of …, 2008 - Elsevier
BACKGROUND: Renal cell carcinoma (RCC) is the sixth leading cause of death in
developed countries. A third of all RCC patients are confronted with metastatic disease …
developed countries. A third of all RCC patients are confronted with metastatic disease …
Present achievements in the medical treatment of metastatic renal cell carcinoma
A Ravaud, M Debled - Critical reviews in oncology/hematology, 1999 - Elsevier
Conclusion Whatever the modest progress made for a small number of patients with MRCC,
the majority of patients will die within 5 years of diagnosis of MRCC. Therefore, there is a …
the majority of patients will die within 5 years of diagnosis of MRCC. Therefore, there is a …
New perspectives on the treatment of metastatic renal cell carcinoma: an introduction and historical overview
RJ Motzer - The oncologist, 2011 - academic.oup.com
New Perspectives on the Treatment of Metastatic Renal Cell Carcinoma: An Introduction and
Historical Overview | The Oncologist | Oxford Academic Skip to Main Content Advertisement …
Historical Overview | The Oncologist | Oxford Academic Skip to Main Content Advertisement …
Treatment options for metastatic renal cell carcinoma: a review.
U Athar, TC Gentile - The Canadian journal of urology, 2008 - europepmc.org
Metastatic renal cell carcinoma (RCC) has a poor overall survival. Localized RCC remains a
surgical disease. About 20%-30% patients who present with limited disease at the time of …
surgical disease. About 20%-30% patients who present with limited disease at the time of …
Review of guidelines on the treatment of metastatic renal cell carcinoma
D Soulières - Current Oncology, 2009 - mdpi.com
Guidelines on the management of metastatic renal cell carcinoma (RCC) have emerged
over the last couple of years because of the introduction of effective new targeted therapies …
over the last couple of years because of the introduction of effective new targeted therapies …
Contemporary treatment of metastatic renal cell carcinoma
P Wiechno, J Kucharz, M Sadowska, W Michalski… - Medical Oncology, 2018 - Springer
Renal cell carcinoma is the 14th most common cancer worldwide. It is a heterogeneous
group of histopathological entities, of which the most common is clear cell renal cell …
group of histopathological entities, of which the most common is clear cell renal cell …
Targeted therapies used sequentially in metastatic renal cell cancer: overall results from a large experience
G Procopio, E Verzoni, R Iacovelli… - Expert review of …, 2011 - Taylor & Francis
Targeted therapies have improved survival in patients with metastatic renal cell cancer
(RCC); however, expert opinion on the optimal therapeutic strategy is divided. This …
(RCC); however, expert opinion on the optimal therapeutic strategy is divided. This …
[HTML][HTML] Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: results from the Danish Renal Cancer …
AV Soerensen, F Donskov, GG Hermann… - European Journal of …, 2014 - Elsevier
Aim To evaluate the implementation of targeted therapy on overall survival (OS) in a
complete national cohort of patients with metastatic renal cell carcinoma (mRCC). Methods …
complete national cohort of patients with metastatic renal cell carcinoma (mRCC). Methods …
Treatment of metastatic renal cell carcinoma
DJ Reeves, CY Liu - Cancer chemotherapy and pharmacology, 2009 - Springer
Purpose To review the treatment of metastatic renal cell carcinoma (RCC), including the use
of new targeted therapies. Methods A search of MEDLINE (1966 to August 2008) and …
of new targeted therapies. Methods A search of MEDLINE (1966 to August 2008) and …
Prognostic factors for survival in metastatic renal cell carcinoma: retrospective analysis from 109 consecutive patients
G Citterio, A Bertuzzi, M Tresoldi, L Galli, G Di Lucca… - European …, 1997 - karger.com
Objective: Metastatic renal cell cancer (RCC) portends a bad prognosis, but survival is quite
different among different patients. The objective of this study was to determine prognostic …
different among different patients. The objective of this study was to determine prognostic …